Science Publishing Evolves: Greed or Need?

At Cornell University there is "preliminary discussion on a national symposium" to be held at the upstate New York campus to discuss, among other things, the rising costs of subscriptions to commercially published academic journals, according to Ross Atkinson, Cornell's deputy university librarian. The backdrop for the potential symposium? A number of recent significant events in the world of academic publishing: The release in December 1998 of the Journal Price Study1 by a Cornell Universit

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

At Cornell University there is "preliminary discussion on a national symposium" to be held at the upstate New York campus to discuss, among other things, the rising costs of subscriptions to commercially published academic journals, according to Ross Atkinson, Cornell's deputy university librarian.

The backdrop for the potential symposium? A number of recent significant events in the world of academic publishing:

High journal-subscription costs have been a simmering topic in academic library circles for several years. And a number of academics don't hesitate when asked why commercially published journals are so costly. "They have stockholders that are interested in profits, I presume," says Kraig Adler, professor of biology at Cornell, who chaired the committee study. "We didn't come right out and say it's greed, but I don't see any other really good explanation."

Martin Rosenzweig "Profiteering is what I call it," asserts Rosenzweig, adding the commercial publishers are concerned about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies